Imunexus was pleased to present at the 2026 Impact Investment Summit Asia Pacific, held at the International Convention Centre Sydney on 25-26 March.
Executive Chair and CEO Philippa Lewis, and CSO Dr George Topsides generated significant interest following their presentation, which was very well received by attendees.
Founded in 2015, the Impact Investment Summit is recognised as the premier event for investors in the Asia-Pacific region looking to connect, learn and invest to scale positive impact. It brings together investors, advisors, foundations, family offices, government and organisations to explore opportunities that deliver financial and positive impact outcomes.